ArticleBioscience reports2023
Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.